Clinical imaging in anti-atherosclerosis drug development-Reference-Cited by-同舟云学术

Clinical imaging in anti-atherosclerosis drug development

Published:2015-11 Issue:11 Volume:20 Page:1317-1327
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Ehlgen Alexander,Bylock Anders,Kreuzer Jörg,Koslowski Michael,Gantner Florian,Niessen Heiko G.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference65 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Pedersen;Lancet,1994

2. Imaging of atherosclerosis;Owen;Annu. Rev. Med.,2011

3. Utility of atherosclerosis imaging in the evaluation of high-density lipoprotein-raising therapies;Duivenvoorden;Curr. Atheroscler. Rep.,2011

4. The role of carotid arterial intima-media thickness in predicting clinical coronary events;Hodis;Ann. Intern. Med.,1998

5. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993;Chambless;Am. J. Epidemiol.,1997

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The amelioration of a purified Pleurotus abieticola polysaccharide on atherosclerosis in ApoE^−/− mice;Food & Function;2024

2. Development of triglyceride-lowering drugs to address residual cardiovascular risk: strategic and clinical considerations;European Heart Journal - Cardiovascular Pharmacotherapy;2018-07-27

3. The use of echocardiography for the non-invasive evaluation of coronary artery disease;Annals of Medicine;2016-11-12

4. Tools in Clinical Pharmacology: Imaging Techniques;Clinical Pharmacology: Current Topics and Case Studies;2016